{"product_id":"therapeutic-drug-monitoring-market-by-product-consumables-equipment-immunoassay-analyzers-chromatography-ms-detectors-clinical-chemistry-analyzers-technology-class-of-drugs-end-user-and-region-global-forecast-to-2027","title":"Therapeutic Drug Monitoring Market by Product (Consumables, Equipment-Immunoassay Analyzers, Chromatography \u0026 MS Detectors, Clinical Chemistry Analyzers), Technology, Class of drugs, End user and Region - Global Forecast to 2027","description":"\u003cp\u003eTherapeutic Drug Monitoring Market by Product (Consumables, Equipment-Immunoassay Analyzers, Chromatography \u0026amp; MS Detectors, Clinical Chemistry Analyzers), Technology, Class of drugs, End user and Region - Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global therapeutic drug monitoring market is projected to reach USD  2.9 billion by 2027 from USD  1.8 billion in 2022, at a CAGR of 9.6% during the forecast period. The growth of this market is majorly driven by a high awaiting number of organ transplant procedures and the expanding inclination for precision medicine. However, a lack of infrastructure and low awareness in middle\/low-income countries may challenge the growth of this market.\u003c\/p\u003e\n\n \u003cp\u003e“Liquid Chromatography-Mass Spectrometry in the technology segment to witness the highest growth during the forecast period.”\u003c\/p\u003e\n\n\u003cp\u003eBased on the technology, the Therapeutic Drug Monitoring Market is segmented into Immunoassays - Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-MS - LC-MS, GC-MS, The LC-MS is projected to grow at the highest CAGR during the forecast period. The significant factors contributing to the growth of this market are affordability, reliability, and its availability in automated platform, as well as wide benefits of advanced HPLC usage in TDM drugs. \u003cbr\u003e\n \u003cbr\u003e\n“Asia Pacific is estimated to register the highest CAGR during the forecast period.”\u003c\/p\u003e\n\n\u003cp\u003eIn this report, the Therapeutic Drug Monitoring market is segmented into four major regional segments: North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the upsurging population (especially in Japan and China), availaibility of comprehensive government healthcare coverage in Japan (for transplantation \u0026amp; related diagnostic procedures), government efforts to increase awareness about primitive disease detection and health check-ups, rising government expenditure in China and India to remodel and expand healthcare infrastructure, and the growing prevalence of severe diseases\u003c\/p\u003e\n\n\u003cp\u003eBreakdown of supply-side primary interviews, by company type, designation, and region:\u003c\/p\u003e \n\n\u003cp\u003eBy Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)\u003c\/p\u003e \n\n\u003cp\u003eBy Designation: C-level (30%), Director-level (34%), and Others (36%)\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America (40%), Europe (28%), AsiaPacific (20%), and  Rest of the World(12%)\u003c\/p\u003e \n\n\u003cp\u003eList of Companies Profiled in the Report\u003c\/p\u003e\n\n\u003cp\u003eAbbott (US)\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific (US)\u003c\/p\u003e\n\n\u003cp\u003eF. Hoffmann-La Roche Ltd. (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eSiemens Healthineers AG (Germany)\u003c\/p\u003e\n\n\u003cp\u003eDanaher Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eBio-Rad Laboratories (US)\u003c\/p\u003e\n\n\u003cp\u003ebioMérieux SA (France)\u003c\/p\u003e\n\n\u003cp\u003eTheradiag SA (France)\u003c\/p\u003e\n\n\u003cp\u003eGrifols S.A. (Spain)\u003c\/p\u003e\n\n\u003cp\u003eExagen Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eR-Biopharm AG (Germany)\u003c\/p\u003e\n\n\u003cp\u003eARK DIAGNOSTICS, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCambridge Life Sciences Limited (UK)\u003c\/p\u003e\n\n\u003cp\u003eBÜHLMANN Laboratories (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eIMMUNDIAGNOSTIK AG (Germany)\u003c\/p\u003e\n\n\u003cp\u003eBioTeZ Berlin-Buch GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eUTAK (US)\u003c\/p\u003e\n\n\u003cp\u003eDiaSystem Scandinavia AB (Sweden)\u003c\/p\u003e \n\n\u003cp\u003eJasem Laboratory Systems and Solutions (Turkey)\u003c\/p\u003e\n\n\u003cp\u003eAalto Scientific, Ltd. (US)\u003c\/p\u003e\n\n\u003cp\u003eapDia Group (Belgium)\u003c\/p\u003e\n\n\u003cp\u003eSJK Global, LLC. (US)\u003c\/p\u003e\n\n\u003cp\u003eEpitope Diagnostics, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eSekisui Medical Co. Ltd. (Japan)\u003c\/p\u003e \n\n\u003cp\u003eEagle Biosciences, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eChromsystems Instruments \u0026amp; Chemicals GmbH (Germany)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the Therapeutic Drug Monitoring market based on product and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Therapeutic Drug Monitoring market. The report forecasts the revenue of the market segments with respect to five major regions.\u003cbr\u003e\n \u003cbr\u003e\nReasons to Buy the Report:\u003c\/p\u003e \n\n\u003cp\u003eThe report provides insights on the following pointers:\u003c\/p\u003e\n\n\u003cp\u003eMarket Penetration: Comprehensive information on Therapeutic Drug Monitoring products offered by the top 26 players in the therapeutic drug monitoring market. The report analyzes the therapeutic drug monitoring market by product, and region.\u003c\/p\u003e \n\n\u003cp\u003eMarket Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.\u003c\/p\u003e\n\n\u003cp\u003eMarket Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Therapeutic Drug Monitoring market\u003c\/p\u003e \n\n\u003cp\u003eCompetitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Therapeutic Drug Monitoring market\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 214 Pages \/ MCW16227186","offer_id":47645916004658,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true},{"title":"February, 2023 \/ 214 Pages \/ MCW16227187","offer_id":47645916037426,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/therapeutic-drug-monitoring-market-by-product-consumables-equipment-immunoassay-analyzers-chromatography-ms-detectors-clinical-chemistry-analyzers-technology-class-of-drugs-end-user-and-region-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}